4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD

<p>51 wet AMD patients with severe disease activity </p>
<p>The post <a href="https://forextv.com/top-news/4dmt-presents-positive-interim-data-from-randomized-phase-2-prism-clinical-trial-of-intravitreal-4d-150-demonstrating-favorable-tolerability-clinical-activity-in-wet-amd/">4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability &amp; Clinical Activity in Wet AMD</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>